A

Asymchem Laboratories Tianjin Co Ltd
SZSE:002821

Watchlist Manager
Asymchem Laboratories Tianjin Co Ltd
SZSE:002821
Watchlist
Price: 77.04 CNY -0.81% Market Closed
Market Cap: 28.3B CNY
Have any thoughts about
Asymchem Laboratories Tianjin Co Ltd?
Write Note

Asymchem Laboratories Tianjin Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Asymchem Laboratories Tianjin Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
A
Asymchem Laboratories Tianjin Co Ltd
SZSE:002821
Income from Continuing Operations
ÂĄ750.2m
CAGR 3-Years
-6%
CAGR 5-Years
7%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Income from Continuing Operations
ÂĄ3.3B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Income from Continuing Operations
ÂĄ3.1B
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Income from Continuing Operations
ÂĄ5.4B
CAGR 3-Years
-5%
CAGR 5-Years
2%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Income from Continuing Operations
ÂĄ4.3B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
6%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Income from Continuing Operations
-ÂĄ780.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Asymchem Laboratories Tianjin Co Ltd
Glance View

Market Cap
28.5B CNY
Industry
Pharmaceuticals

In the bustling industrial landscape of Tianjin, Asymchem Laboratories stands as a beacon of innovation and precision in the biopharmaceutical world. Founded with a vision to harmonize the intricate processes of pharmaceutical development, Asymchem has evolved into a powerhouse of Contract Development and Manufacturing Organization (CDMO) services. The company provides end-to-end solutions in the pharmaceutical sector, specializing in the synthesis and manufacturing of small molecule active pharmaceutical ingredients (APIs). Their sophisticated laboratories and state-of-the-art production facilities serve a global clientele, demanding not only high-quality standards but also a seamless integration of complex processes—from drug discovery through commercialization. Asymchem's business model thrives on the symbiosis between its technical expertise and the ever-growing demand for innovative pharmaceuticals. They offer a comprehensive suite of services including research and development, process optimization, and full-scale commercial production. The company's revenue streams are tied to its ability to win long-term contracts with major pharmaceutical companies, focusing on creating custom-tailored solutions that expedite the drug development timeline while ensuring compliance with stringent regulatory standards. By aligning their operations with the needs of the biopharmaceutical industry, Asymchem secures its positioning as a key player, propelling forward the possibilities of modern medicine while ensuring sustainable growth in the competitive pharmaceutical manufacturing sector.

Intrinsic Value
101.51 CNY
Undervaluation 24%
Intrinsic Value
Price
A

See Also

What is Asymchem Laboratories Tianjin Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
750.2m CNY

Based on the financial report for Sep 30, 2024, Asymchem Laboratories Tianjin Co Ltd's Income from Continuing Operations amounts to 750.2m CNY.

What is Asymchem Laboratories Tianjin Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
7%

Over the last year, the Income from Continuing Operations growth was -73%. The average annual Income from Continuing Operations growth rates for Asymchem Laboratories Tianjin Co Ltd have been -6% over the past three years , 7% over the past five years .

Back to Top